RepublicBankAz Announces Unaudited Financial Results For

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
RepublicBankAz Announces Unaudited Financial Results For the Quarter Ending June 30, 2016

PHOENIX, Aug. 02, 2016 (GLOBE NEWSWIRE) -- RepublicBankAz,N.A. (OTCBB: RBAZ ) (“RBAz”) announced a net income of $56,000, or $.03 per share, for the quarter ended June 30, 2016 as compared to a net income of $95,000 or $.07 per share for the same period in 2015.

President and CEO Ralph Tapscott stated, “Our quarter ended June 30, 2016 earnings of $56,000 and resulting ROA of 0.24% are not indicative of the strides we have made during 2016. We are, however, pleased that our year to date results of $206,000 in income and the resultant ROA of 0.46% are trending toward the results we saw for the year ended December 31, 2015. I’m confident, however, that our efforts will result in future earnings results that are more positive than we saw this quarter. Significant strides continue to be made to guide RepublicBankAz to safe and sound operations.”

Second Quarter Highlights Include:

  • Total Assets have grown $6.0 million and total deposits have grown $5.5 million since December 31, 2015 which represents annualized growth rates of 14% and 15%, respectively.
  • Nonperforming assets as a percentage of total assets fell to 2.91% as of June 30, 2016 an 11.8% improvement from the level at December 31, 2015.
  • Equity capital has grown 3.84% or $496,000 since December 31, 2015.
  • The Bank’s liquidity ratio improved to 35.7% as of June 30, 2016 from 23.72% as of December 31, 2015.
  • Total securities grew 47.1% since December 31, 2015 to a level of $20,815,000 as of June 30, 2016.
  • Non-interest expense of $871,000 for the second quarter of 2016 improved 7.2% from the second quarter of 2015.

“Management is focused on growing the bank by providing credit and cash management services for small to midsize businesses,” noted Tapscott. “As the Arizona economy continues to improve, so does the strength of the business sector and our ability to increase our market share within this sector.”

The Bank remains “well capitalized” as follows:
           
    June 30, 2016 (%)     Ratio to be Well Capitalized (%)
Leverage Ratio     14.25       5.00
Tier 1 Capital to Risk Weighted Assets     22.10       6.00
Total Capital to Risk Weighted Assets     23.38       10.00
           

About the Company RepublicBankAz,N.A. is a locally owned community bank in Phoenix, Arizona.  RBAz is a full service community bank providing deposit and loan products, and convenient on-line banking to individuals, businesses and professionals.  The Bank was established in April 2007 and operates out of a single location at 909 E. Missouri Avenue. The Bank is traded over-the-counter as RBAZ.  For further information, please visit our web site: www.republicbankaz.com .

Forward-looking Statements This press release may include forward-looking statements about RBAz, for which the Bank claims the protection of safe harbor provisions contained in the Private Securities Litigation Reform Act of 1995.  Forward-looking statements are based on management’s knowledge and belief as of today and include information concerning the Bank’s possible or assumed future financial condition, and its results of operations and business. Forward-looking statements are subject to risks and uncertainties.  A number of important factors could cause actual results to differ materially from those in the forward-looking statements. Those factors include fluctuations in interest rates, government policies and regulations (including monetary and fiscal policies), legislation, economic conditions, borrower capacity to repay, operational factors and competition in the geographic and business areas in which the Bank conducts its operations.  All forward-looking statements included in this press release are based on information available at the time of the release, and the Bank assumes no obligation to update any forward-looking statement.

Unaudited Summary Financial Information
       
  For the three months ended June 30, For the Six months ended June 30,   Year-End
  2016     2015     2016     2015     2015  
  (dollars in thousands, except per share data)
Summary Income Data          
Interest income $   1,068   $   1,187   $   2,325   $   2,389   $   4,873  
Interest expense   188     174     367     347     697  
Net interest income   880     1,013     1,958     2,042     4,176  
Provision for loan losses   -     -     -     -     24  
Non-interest income   40     87     86     170     313  
Non-interest expense   871     939     1,742     1,863     3,475  
Realized gains (losses) on sales of securities   22     -     22     -     -  
Income (loss) before income taxes   71     161     324     349     990  
Provision for income tax (benefit)   15     66     118     141     364  
Net income (loss)   56     95     206     208     626  
Per Share Data:          
Shares outstanding end-of-period   1,702     1,378     1,702     1,378     1,702  
Earnings per common share   0.03     0.07     0.12     0.15     0.37  
Cash dividend declared   -     -     -     -     -  
Total shareholders’ equity $   13,415   $   11,354   $   13,415   $   11,354   $   12,919  
Book value per share   7.88     8.24     7.88     8.24     7.59  
Selected Balance Sheet Data:          
Total assets $ 91,749   $ 85,111   $ 91,749   $  85,111   $  85,724  
Securities available-for-sale   20,815     9,608     20,815     9,608     14,150  
Securities held-to-maturity   -     -     -     -     -  
Loans   61,379     69,814     61,379     69,814     66,508  
Allowance for loan losses   2,115     2,305     2,115     2,305     2,268  
Deposits   76,117     71,445     76,117     71,445     70,616  
Other borrowings   1,950     1,950     1,950     1,950     1,950  
Shareholders’ equity   13,415     11,354     13,415     11,354     12,919  
Performance Ratios:          
Return on average shareholders’ equity (annualized)   1.69     3.35     3.13     3.68     5.28  
Net interest margin (%)   3.84     4.79     4.47     4.84     4.91  
Average assets   92,206     85,476     89,609     86,253     87,075  
Return on average assets (annualized) (%)   0.24     0.44     0.46     0.48     0.72  
Shareholders’ equity to assets (%)   14.62     13.34     14.62     13.34     15.07  
Efficiency ratio (%)   94.67     85.36     85.23     84.22     77.61  
Asset Quality Data:          
Nonperforming loans   2,371     2,056     2,371     2,056     2,526  
Other real estate and repos   303     433     303     433     303  
Nonperforming assets   2,674     2,489     2,674     2,489     2,829  
Nonperforming assets to total assets (%)   2.91     2.92     2.91     2.92     3.30  
Nonperforming loans to total loans (%)   3.86     2.94     3.86     2.94     3.80  
Reserve for loan losses to total loans (%)   3.45     3.30     3.45     3.30     3.41  
Reserve for loan losses to nonperforming loans (%)    89.20     112.11     89.20     112.11     89.79  
Reserve for loan losses to nonperforming assets (%)   79.09     92.61     79.09     92.61     80.17  
Net charge-offs for period   -     -     162     -     78  
Average loans   62,285     70,993     61,822     70,826     70,756  
Ratio of charge‑offs to average loans (%)   -      -    .26    -      0.11   
Regulatory Capital Ratios:          
Tier 1 leverage capital ratio (%)   14.25     13.17     14.25     13.17     14.53  
Tier 1 risk-based capital ratio (%)   22.10     17.52     22.10     17.52     20.83  
Total risk-based capital ratio (%)   23.38     18.80     23.38     18.80     22.11  

 

Contact: Ralph Tapscott, President and Chief Executive Officer Phone: 602.280.9403 Email: rtapscott@republicaz.com

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Sebela Pharma's Tegoprazan Posts Strong Phase 3 Data

Updated Category News Views 7

Spotlight on Tegoprazan: A New Player on the GERD Field Sometimes, a pharma company turns heads with data that speaks for itself. This time, Sebela Pharmaceuticals is doing just that with Tegoprazan's phase 3 results, shining a light on an area overlooked for too long: non-erosive reflux disease (NERD). Showing promise in its latest trials, Tegoprazan is muscling into the...

Continue Reading
LEGO Mashes Star Wars and Marvel for Fans' Delight

Updated Category News Views 7

A New Chapter in LEGO's Story Well, well, what do we have here? LEGO's throwing down the gauntlet. For the first time, they're asking fans to merge two colossal universes: Star Wars and Marvel. Talk about a brains-and-bricks bonanza! Announced at New York Comic Con with some star power from Kevin Smith, this LEGO Ideas challenge opens doors for fan creativity that might...

Continue Reading
Phase I of 2026 Hong Kong Trade Shows Highlights Innovation

Updated Category News Views 9

Hong Kong Takes Center Stage in Global Commerce Flip through the economic landscape today, and you’ll spot Hong Kong, decked out in its best as a trade linchpin—with over 2,100 suppliers gathered under one roof. AsiaWorld-Expo is buzzing with the commencement of Phase I of the October 2026 Global Sources Hong Kong Shows. The theme's all about 'Connecting Global...

Continue Reading
Southern Company Sparks Swift Power Restoration Post-Isaias

Updated Category News Views 11

Well, when Mother Nature decides to throw a tantrum, it takes seasoned hands and savvy tech to clean up the mess. That's exactly what Southern Company is doing after Hurricane Isaias wreaked havoc on the Southeast. With their electric utilities—Alabama Power, Georgia Power, and Mississippi Power—hitting the ground running, they've already restored power to a whopping...

Continue Reading
AbbVie's SKYRIZI and RINVOQ Highlight IBD Control Advances

Updated Category News Views 5

A Deeper Look Into AbbVie's Latest Data Let's cut straight to the science, folks. At the recent American College of Gastroenterology 2026 Annual Scientific Meeting, AbbVie pulled the curtain on 22 fresh scientific abstracts that are really shaking things up in the field of inflammatory bowel disease (IBD) treatment. Data from the Phase 3 AFFIRM study shined especially...

Continue Reading
Celltrion Unveils New Data on Infliximab: ACG 2026 Insight

Updated Category News Views 4

First Impressions: Celltrion's Latest Revelation Alright, let's jump straight into it. Celltrion USA is flaunting its latest findings on ZYMFENTRA® (infliximab-dyyb) for Crohn's disease and ulcerative colitis right at the American College of Gastroenterology's (ACG) grand event in 2026. If you've been watching the healthcare sector, this is significant news. It's got all...

Continue Reading
AI Drives Major Time Savings in Endoscopy Tech

Updated Category News Views 10

AI in Endoscopy: Game-Changer or Gimmick? Stumbling across AnX Robotica's latest pitch about their NaviCam ProScan AI workflow, one can't help but feel a mix of curiosity and skepticism. With the stakes in medical tech sky-high, they've fired off some impressive stats that grab attention. We're talking about cutting small-bowel capsule review times by a whopping...

Continue Reading
2026 Community Impact Week: Slam Dunk for Community Unity

Updated Category News Views 6

Alright, if you're looking for a story that gives you those warm fuzzy feelings while wrapping you in a big sports hug, here it is. Imagine this: you've got basketball legends, world-class athletes, and a corporate heavyweight, all huddling up to make a community impact that's more than just warm air. Hoops, Hope, and High Fives The NBA Cares x Sands Cares Community...

Continue Reading
NARUTO Card Game Set for June 2027 Global Launch

Updated Category News Views 11

Mark Your Calendars: Global Launch June 2027 They're rolling out a red carpet for nostalgia here, I tell ya! At the New York Comic Con, BANDAI announced a worldwide launch for the NARUTO CARD GAME in June 2027. We'll see pre-built decks starring your favorite shinobi and a mad sprint to collect with the new booster packs. Feels sort of like they’re summoning a jutsu...

Continue Reading
Duolingo Faces Lawsuit Over Alleged Investor Missteps

Updated Category News Views 10

Fasten your seatbelts, folks. We're diving into a legal tussle that could shake things up for Duolingo, Inc. (NASDAQ: DUOL). Investors who plunged into Duolingo shares between May 2, 2025, and February 26, 2026, might be feeling the heat now. They ought to brace for a class-action lawsuit frenzy with fingers pointed at Duolingo for allegedly pulling wool over investors'...

Continue Reading

Top 5 Most Recently Viewed Articles

Samer Alkhaldi Joins HFM to Drive Business Growth in MENA Region

Updated Category News Views 65

Samer Alkhaldi Takes Charge at HFM for MENA Development In an exciting development for HFM, a prominent player in global online trading, Samer Alkhaldi has been appointed as the new Regional Head of Business Development for the MENA region. With an extensive background in the financial sector, Samer’s appointment is a significant strategy to expand and improve services...

Continue Reading
Kenyan Government's Strategic Shift Towards Digital Operations

Updated Category News Views 286

Kenya's Digital Transformation with Danish F2 Platform The Kenyan government is embarking on an exciting journey towards digital transformation by adopting the Danish F2 platform. This innovative initiative was shared by the Ministry of Information, Communications, and the Digital Economy, aiming to streamline processes across various governmental departments. Objective...

Continue Reading
Brookfield Corporation Plans Upcoming Investor Day Event

Updated Category News Views 210

Brookfield Corporation's Investor Day Announcement Brookfield Corporation (NYSE: BN, TSX: BN) and Brookfield Asset Management Ltd. (NYSE: BAM, TSX: BAM) are gearing up for a significant Investor Day scheduled for a Wednesday in New York. This event aims to engage investors with insights on the company's strategic direction and performance metrics. Event Details The...

Continue Reading
Virtune Updates on MarketVector's Pricing Changes for ETPs

Updated Category News Views 155

Virtune Announces Important Pricing Update for ETPs Virtune, a leading player in digital asset management, has shared significant news regarding its approach to the pricing of its exchange-traded products (ETPs). Effective December 4, 2025, the company will update its reference price provider MarketVector, switching the underlying price source for its crypto assets used...

Continue Reading
Accessible Healthcare Support for Wildfire Affected Residents

Updated Category News Views 157

Virtual Healthcare Appointments for Affected Residents In light of the recent wildfires in Southern California, those who have faced displacement or adversity due to these events can now access more no-cost virtual healthcare appointments. This initiative is expanding to ensure that residents in Los Angeles can receive urgent medical attention, including vital services...

Continue Reading